{
 "drug": "Ifosfamide Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "06/12/2026",
 "dayN": 74,
 "cat": "Oncology",
 "companies": [
  "Hikma Pharmaceuticals USA, Inc.",
  "Fresenius Kabi USA, LLC",
  "Baxter Healthcare"
 ],
 "reasons": [
  "Demand increase for the drug",
  "Requirements related to complying with good manufacturing practices"
 ],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "0143-9531-01",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Additional lots will be available in the September 2026 timeframe.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA076619"
    ],
    "brand_name": [
     "IFOSFAMIDE"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9531",
     "0143-9530"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791597",
     "1791599"
    ],
    "spl_id": [
     "517c3bf6-41f5-4199-a17e-1f46b120cb1e"
    ],
    "spl_set_id": [
     "c90ab05f-8fe5-437e-a1c0-8b11ef63291e"
    ],
    "package_ndc": [
     "0143-9531-01",
     "0143-9530-01"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "63323-142-10",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "888-386-1300",
   "availability": "Unavailable",
   "related_info": "Next release August 2026",
   "openfda": {
    "application_number": [
     "ANDA076078"
    ],
    "brand_name": [
     "IFOSFAMIDE"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-142"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791593"
    ],
    "spl_id": [
     "8f166a04-4395-4ea1-8eda-98274f1bfec3"
    ],
    "spl_set_id": [
     "a311a947-7b78-4226-bfe0-f4aa0be20e27"
    ],
    "package_ndc": [
     "63323-142-10"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Ifosfamide, Injection, 1 g (NDC 63323-142-10)",
   "company_name": "Fresenius Kabi USA, LLC",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "0143-9530-01",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "800-631-2174",
   "availability": "Unavailable",
   "related_info": "Additional lots will be available in the September 2026 timeframe.  Product will be made available as it is released.",
   "openfda": {
    "application_number": [
     "ANDA076619"
    ],
    "brand_name": [
     "IFOSFAMIDE"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Hikma Pharmaceuticals USA Inc."
    ],
    "product_ndc": [
     "0143-9530",
     "0143-9531"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791597",
     "1791599"
    ],
    "spl_id": [
     "517c3bf6-41f5-4199-a17e-1f46b120cb1e"
    ],
    "spl_set_id": [
     "c90ab05f-8fe5-437e-a1c0-8b11ef63291e"
    ],
    "package_ndc": [
     "0143-9531-01",
     "0143-9530-01"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/13/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)",
   "company_name": "Hikma Pharmaceuticals USA, Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "0338-3993-01",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "888-229-0001",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: October 2026",
   "openfda": {
    "application_number": [
     "NDA019763"
    ],
    "brand_name": [
     "IFEX"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-3993",
     "0338-3991"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791588",
     "1791591",
     "1791593",
     "1791595"
    ],
    "spl_id": [
     "56f50d8e-7c87-4119-a7dc-bfd77fa3dcec"
    ],
    "spl_set_id": [
     "b7241707-7538-4d1a-91e7-3a25a91e0b9a"
    ],
    "package_ndc": [
     "0338-3991-01",
     "0338-3993-01"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "10019-925-01",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "888-229-0001",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "NDA019763"
    ],
    "brand_name": [
     "IFOSFAMIDE"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "10019-925",
     "10019-926"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791588",
     "1791593"
    ],
    "spl_id": [
     "d505027a-76e6-49f1-8ed1-3eeffe9a958b"
    ],
    "spl_set_id": [
     "91e433a9-6800-43a6-ac13-a49a04a5aecd"
    ],
    "package_ndc": [
     "10019-925-82",
     "10019-925-01",
     "10019-926-16",
     "10019-926-02"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "0338-3991-01",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "888-229-0001",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: October 2026",
   "openfda": {
    "application_number": [
     "NDA019763"
    ],
    "brand_name": [
     "IFEX"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Corporation"
    ],
    "product_ndc": [
     "0338-3991",
     "0338-3993"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791588",
     "1791591",
     "1791593",
     "1791595"
    ],
    "spl_id": [
     "56f50d8e-7c87-4119-a7dc-bfd77fa3dcec"
    ],
    "spl_set_id": [
     "b7241707-7538-4d1a-91e7-3a25a91e0b9a"
    ],
    "package_ndc": [
     "0338-3991-01",
     "0338-3993-01"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "06/12/2026",
   "package_ndc": "10019-926-02",
   "generic_name": "Ifosfamide Injection",
   "contact_info": "888-229-0001",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: September 2026",
   "openfda": {
    "application_number": [
     "NDA019763"
    ],
    "brand_name": [
     "IFOSFAMIDE"
    ],
    "generic_name": [
     "IFOSFAMIDE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "10019-926",
     "10019-925"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "IFOSFAMIDE"
    ],
    "rxcui": [
     "1791588",
     "1791593"
    ],
    "spl_id": [
     "d505027a-76e6-49f1-8ed1-3eeffe9a958b"
    ],
    "spl_set_id": [
     "91e433a9-6800-43a6-ac13-a49a04a5aecd"
    ],
    "package_ndc": [
     "10019-925-82",
     "10019-925-01",
     "10019-926-16",
     "10019-926-02"
    ],
    "nui": [
     "N0000000236",
     "N0000175558"
    ],
    "pharm_class_moa": [
     "Alkylating Activity [MoA]"
    ],
    "pharm_class_epc": [
     "Alkylating Drug [EPC]"
    ],
    "unii": [
     "UM20QQM95Y"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Oncology",
    "Pediatric"
   ],
   "dosage_form": "Injection",
   "presentation": "Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Requirements related to complying with good manufacturing practices",
   "status": "Current"
  }
 ]
}